Related Articles
<em>In silico</em> and<em> in vitro</em> study of FLT3 inhibitors and their application in acute myeloid leukemia
Paclitaxel mediates the PI3K/AKT/mTOR pathway to reduce proliferation of FLT3‑ITD<sup>+</sup> AML cells and promote apoptosis
Targeting of STAT5 using the small molecule topotecan hydrochloride suppresses acute myeloid leukemia progression
Internal tandem duplication and tyrosine kinase domain mutations in FLT3 alter the response to daunorubicin in Ba/F3 cells
Discovery of LDD‑1075 as a potent FLT3 inhibitor